While HPV is linked to cervical cancer, not every infection is dangerous, and with regular screening and vaccination, most cases of the disease can be prevented.

February 17, 2010 – It is well established that patients with squamous cell carcinoma of the oropharynx that tests positive for human papillomavirus (HPV) have a more favorable outcome and are more ...

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according ...

Researchers tested the tool in 397 patients with clinically node-positive, HPV-driven oropharyngeal squamous cell carcinoma who underwent chemoradiation between 2009 and 2020.

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.

AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination. HealthDay News — Version 9 of the American Joint Committee on Cancer (AJCC) ...

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which "reset the bar" for future trials of ...

Most of the currently available circulating tumor DNA (ctDNA) technologies provide a high level of diagnostic accuracy for detecting human papillomavirus (HPV)-associated oropharyngeal squamous cell ...

A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma. Economic ...

CLEVELAND — Fenofibrate, patented in 1969 and in medical use since 1975, is well-established as a cholesterol-lowering treatment. However, University Hospitals scientists believe it may also have the ...